REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Laboratorio Clinico Nora Alvarez Sas. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Ips Laboratorio Clinico Nora Alvarez Sas. Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Ips Laboratorio Clinico Nora Alvarez Sas. is an enterprise based in Colombia. Its main office is in Yopal. The company operates in the Diagnostic Imaging Centers industry. The enterprise was incorporated on June 04, 2008. From the latest financial highlights, Ips Laboratorio Clinico Nora Alvarez Sas. reported a net sales revenue increase of 11.86% in 2025. Its’ total assets recorded a growth of 9.66%. The net profit margin of Ips Laboratorio Clinico Nora Alvarez Sas. increased by 4.45% in 2025.

Headquarters
Carrera 23 N. 12 - 43
Yopal; Casanare;

Contact Details: Purchase the Ips Laboratorio Clinico Nora Alvarez Sas. report to view the information.

Basic Information
Registered Capital:
Purchase the Ips Laboratorio Clinico Nora Alvarez Sas. report to view the information.
Financial Auditors:
Purchase the Ips Laboratorio Clinico Nora Alvarez Sas. report to view the information.
Incorporation Date:
June 04, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Laboratorio Clinico Nora Alvarez Sas. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.86%
Total Operating Revenue
11.86%
Operating Profit
93.16%
EBITDA
91.72%
Net Profit/Loss for the Period
114.73%
Total Assets
9.66%
Total Equity
17.2%
Operating Profit Margin
7.24%
Net Profit Margin
4.45%
Return on Equity (ROE)
8.58%
Debt / Equity
4.49%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?